Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses.
about
Cognition enhancers for the treatment of dementia.Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.Increased risk of dementia in patients with mild traumatic brain injury: a nationwide cohort study.Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia.Elevated OPRD1 promoter methylation in Alzheimer's disease patients.Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer's DiseaseIncreased Long-Term Risk of Dementia in Patients With Carbon Monoxide Poisoning: A Population-Based Study.Once-daily memantine: a guide to its use in moderate to severe Alzheimer's disease in the EU.The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.Structure of N-terminal sequence Asp-Ala-Glu-Phe-Arg-His-Asp-Ser of Aβ-peptide with phospholipase A2 from venom of Andaman Cobra sub-species Naja naja sagittifera at 2.0 Å resolution.Benefits and risks of add-on therapies for Alzheimer's disease.Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations.Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.Cost effectiveness of an intervention focused on reducing bathing disability.Impact of 6-month aerobic exercise on Alzheimer's symptoms.Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.Alzheimer's disease Archimedes condition-event simulator: Development and validation.The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
P2860
Q30872331-CBEA5C32-0439-4C00-AD90-A52054B9DFA6Q34575780-0375D427-A50E-480F-8962-C7AF19C0898DQ34712502-43AA2E4A-4375-4D16-8598-6B6899EB42E7Q35054331-9D788B28-4716-499D-98E5-569119125EBBQ36295228-A251EF66-53AE-4773-9A29-78CDA5072842Q37044127-0DCBF3DA-3820-4690-A9D2-FDAD3F735833Q37204987-40CDE2AC-CB1F-4FE2-A389-9B7347B2E218Q38066412-5C332BE3-FD16-414A-80D0-EC58245F67A6Q38167693-DA1F1F92-F36D-4954-8257-B20BE35F0F2CQ38612518-C4DE35AF-7C6F-429C-A94A-1C91559F050BQ38620338-412E0734-A088-4F13-BEC9-F8CE05262998Q38743343-CC4C8007-D3AE-4506-91CB-F30562D1D9A6Q38749068-A3E2F0F1-4E71-4CF1-9E91-79AD7D09EC66Q39236470-B940F198-E98E-431A-84C1-C9E9E8114DD5Q41636128-E1D37CF9-EFD1-49F4-8229-6D47A3251EACQ47126291-106B29A0-041D-47C7-A248-937003361C8FQ50703534-9B12DBC8-9D87-472F-BDF3-421D6CA01A0AQ52568119-79D02D92-6EC7-48AC-88C5-9A932A77794FQ57177786-BBFB8152-F061-41FF-8C06-571A174E3E1C
P2860
Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Economic evaluation of treatme ...... f cost-effectiveness analyses.
@en
type
label
Economic evaluation of treatme ...... f cost-effectiveness analyses.
@en
prefLabel
Economic evaluation of treatme ...... f cost-effectiveness analyses.
@en
P2093
P2860
P1433
P1476
Economic evaluation of treatme ...... of cost-effectiveness analyses
@en
P2093
Anja Neumann
Judith Dams
Laura Pouryamout
Richard Dodel
P2860
P304
P356
10.2165/11631830-000000000-00000
P577
2012-04-01T00:00:00Z
P6179
1052657836